Healthcare

Follow Our Latest COVID-19 Updates

PHILIPPINES: FDA Updates: Use of Electronic Means of Prescription for Drugs and Registration of Drug Products under Emergency Use

With the enactment of Republic Act No. 11494, or the Bayanihan to Recover as One Act ("Bayanihan Act 2") and the periodic changes on the quarantine status of different localities, the Food and Drug Administration ("FDA") reissued and extended its existing guidelines on: (i) the implementation of the use of electronic means of prescription for drugs; and (ii) the registration of drug products under emergency use ("DEU") for COVID-19.